Page last updated: 2024-09-03

y 27632 and Cancer of Esophagus

y 27632 has been researched along with Cancer of Esophagus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Asano, N; Asanuma, K; Fujiya, T; Imatani, A; Koike, T; Masamune, A; Okata, T; Saito, M1
Li, J; Lu, Y; Wang, L; Xue, L; Yan, H1
Foran, E; Kenny, D; Lawler, K; Long, A; O'Sullivan, G1

Other Studies

3 other study(ies) available for y 27632 and Cancer of Esophagus

ArticleYear
Nitric oxide could promote development of Barrett's esophagus by
    American journal of physiology. Gastrointestinal and liver physiology, 2022, 01-01, Volume: 322, Issue:1

    Topics: Amides; Barrett Esophagus; Cell Differentiation; Epithelial Cells; Esophageal Neoplasms; Fibroblasts; Gastroesophageal Reflux; Humans; Metaplasia; Nitric Oxide; Pyridines; Signal Transduction

2022
Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells.
    Molecular biology reports, 2010, Volume: 37, Issue:4

    Topics: Amides; Carcinoma, Squamous Cell; Cell Adhesion; Cell Line, Tumor; Cell Movement; Esophageal Neoplasms; Humans; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases

2010
Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner.
    American journal of physiology. Cell physiology, 2006, Volume: 291, Issue:4

    Topics: Actins; Amides; Cell Adhesion; Cell Movement; Cells, Cultured; Cytoskeleton; Enzyme Inhibitors; Esophageal Neoplasms; Fibronectins; Humans; Integrin alphaVbeta3; Intracellular Signaling Peptides and Proteins; Neoplasm Invasiveness; Protein Serine-Threonine Kinases; Pyridines; ras Proteins; rho-Associated Kinases; Signal Transduction; Stress, Mechanical; Tissue Distribution; Tubulin

2006